| Literature DB >> 33262956 |
Anh L Diep1, Katrina K Hoyer1,2,3.
Abstract
Coccidioidomycosis is a fungal, respiratory disease caused by Coccidioides immitis and Coccidioides posadasii. This emerging infectious disease ranges from asymptomatic to pulmonary disease and disseminated infection. Most infections are cleared with little to no medical intervention whereas chronic disease often requires life-long medication with severe impairment in quality of life. It is unclear what differentiates hosts immunity resulting in disease resolution versus chronic infection. Current understanding in mycology-immunology suggests that chronic infection could be due to maladaptive immune responses. Immunosuppressed patients develop more severe disease and mouse studies show adaptive Th1 and Th17 responses are required for clearance. This is supported by heightened immunosuppressive regulatory responses and lowered anti-fungal T helper responses in chronic Coccidioides patients. Diagnosis and prognosis is difficult as symptoms are broad and overlapping with community acquired pneumonia, often resulting in misdiagnosis and delayed treatment. Furthermore, we lack clear biomarkers of disease severity which could aid prognosis for more effective healthcare. As the endemic region grows and population increases in endemic areas, the need to understand Coccidioides infection is becoming urgent. There is a growing effort to identify fungal virulence factors and host immune components that influence fungal immunity and relate these to patient disease outcome and treatment. This review compiles the known immune responses to Coccidioides spp. infection and various related fungal pathogens to provide speculation on Coccidioides immunity.Entities:
Keywords: Coccidioides immitis; Coccidioides posadasii; Coccidioidomycosis; Valley fever; fungal immunity; host pathogen interactions
Year: 2020 PMID: 33262956 PMCID: PMC7686801 DOI: 10.3389/fcimb.2020.581101
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Figure 1Fungal dimorphism presents challenges for immune detection and activation. Early infection: Coccidioides is vulnerable to immune detection during early infection due to the smaller size (2–5 μM) and SOWgp expression which is detected via Dectin-1 and TLR2 on innate immune cells. These interactions mediate clearance via phagocytosis and reactive oxide species production. Later infection: As Coccidioides sporulates, it secretes MEP1 which digests SOWgp from the fungal surface, hampering immune detection. Spherules induce arginase expression in host tissues, suppressing NOS/NO production via an unknown mechanism, contributing to immune suppression.
Figure 2Innate immune cell responses to Coccidioides influence adaptive immune cell activation and effector functions. (A) Coccidioides may evade innate immune cell clearance and influence immune functions. (B) Dendritic cells are critical for activating adaptive responses and influencing adaptive immune cell population differentiation.
Resistance to Coccidioides infection in specific strains could be due to immune cellularity differences.
| Mouse Background | Susceptibility to | Alveolar Macrophage Freq. | Lung-resident DC Freq. | Respiratory Leukocyte TNFα production | Respiratory Leukocyte IL-10 production | Lung CD4+CD25+FOXP3+ (Treg) Freq. | Reference Numbers |
|---|---|---|---|---|---|---|---|
| Susceptible | Base | Base | Base | Base | Base | ( | |
| Susceptible | No Δ | No Δ | ↑↑ | ↑↑ | ↑↑ | ( | |
| Resistant | No Δ | No Δ | No Δ | ↓ | ↓ | ( |
The base frequency of cells or cytokine production is in reference to C57BL/6 mice; denoted changes are relative to this strain. Cytokine production was measured post stimulation ex vivo. No Δ, no change from base level; ↑↑, higher than base; ↓, less than base.
Figure 3Regulatory responses correlate with chronic disease outcome. Th17 cells and pro-inflammatory responses are protective against Coccidioides and loss of responses results in increase susceptibility in mice. Modulating effector and regulatory responses might be a potential therapy for chronic infection.